ICON plc (ICLR)

136.55
0.66 0.48
NASDAQ : Health Technology
Prev Close 137.21
Open 137.21
Day Low/High 135.28 / 137.80
52 Wk Low/High 97.12 / 140.26
Volume 177.49K
Avg Volume 197.60K
Exchange NASDAQ
Shares Outstanding 53.79M
Market Cap 7.36B
EPS 5.20
P/E Ratio 26.68
Div & Yield N.A. (N.A)
ICON Is Collaborating With Practice Fusion, Inc. To Advance Health Research

ICON Is Collaborating With Practice Fusion, Inc. To Advance Health Research

ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and medical device industries, today announced that it is working with Practice Fusion to leverage active patient data in support of health...

ICON Enhances Endpoint Adjudication Services Using AG Mednet Advanced Technology

ICON Enhances Endpoint Adjudication Services Using AG Mednet Advanced Technology

ICON plc (NASDAQ: ICLR), a global provider of drug development and commercialisation solutions and services, today announced it has signed an agreement with AG Mednet to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow...

ICON Launches FIRECREST Financial Disclosure To Reduce Administrative Costs And Increase Regulatory Compliance

ICON Launches FIRECREST Financial Disclosure To Reduce Administrative Costs And Increase Regulatory Compliance

ICON plc, (NASDAQ: ICLR) a global provider of drug development and commercialisation solutions and services, today announced the launch of FIRECREST Financial Disclosure, an innovative digital solution that increases the efficiency and compliance of...

ICON Named By Forbes As One Of The Best Employers In America

ICON Named By Forbes As One Of The Best Employers In America

ICON plc , (NASDAQ: ICLR) a global provider of drug development and commercialisation solutions and services, today announced that it has been included in Forbes magazine's America's Best Employers list for 2018.

Saama Technologies And ICON Commercialization And Outcomes Partner To Unlock The Value Of Real World Evidence (RWE)

Saama Technologies And ICON Commercialization And Outcomes Partner To Unlock The Value Of Real World Evidence (RWE)

Saama Technologies, a leading clinical and health data analytics company, and ICON plc (NASDAQ: ICLR), a global provider of drug development and commercialization solutions and services, have partnered to accelerate the use of Real World Evidence (RWE)...

ICON Announces Clinical Research Partnership With DuPage Medical Group

ICON Announces Clinical Research Partnership With DuPage Medical Group

ICON plc (NASDAQ: ICLR), a global provider of drug development and commercialisation solutions and services, today announced that PMG Research, Inc.

ICON Sponsors Industry-Wide Clinical Trials Survey To Support Transforming Trials Initiative

ICON Sponsors Industry-Wide Clinical Trials Survey To Support Transforming Trials Initiative

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the results from a new survey of pharmaceutical executives and professionals by ICON...

ICON Reports First Quarter 2018 Results

ICON Reports First Quarter 2018 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2018.

ICON Announces Launch Of Government And Public Health Solutions To Support Global Public Health

ICON Announces Launch Of Government And Public Health Solutions To Support Global Public Health

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the rebranding of their acquired ClinicalRM...

ICON Reports Fourth Quarter And Full Year 2017 Results

ICON Reports Fourth Quarter And Full Year 2017 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter...

ICON Issues Financial Guidance For Full Year 2018

ICON Issues Financial Guidance For Full Year 2018

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced its financial guidance for the year ended...

ICON Appoints Dr. James Cummings As President Of ClinicalRM

ICON Appoints Dr. James Cummings As President Of ClinicalRM

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr.

ICON Launches FIRECREST Pre-Screen To Improve The Speed And Accuracy Of Identifying Eligible Patients For Screening

ICON Launches FIRECREST Pre-Screen To Improve The Speed And Accuracy Of Identifying Eligible Patients For Screening

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of FIRECREST Pre-Screen, an innovative...

ICON Announces Appointment Of Ms. Joan Garahy To Board Of Directors

ICON Announces Appointment Of Ms. Joan Garahy To Board Of Directors

ICON plc , (NASDAQ: ICLR) global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Ms.

MediMedia Managed Markets, An ICON Company, Wins Two Gold Industry Awards For Data Analytics And Healthcare Communications

MediMedia Managed Markets, An ICON Company, Wins Two Gold Industry Awards For Data Analytics And Healthcare Communications

ICON plc, (NASDAQ: ICLR)) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that MediMedia Managed Markets, an ICON company,...

Medidata Selected By ICON To Evolve Image Management And Accelerate Research Goals For Sponsors And Sites During Clinical Trials

Medidata Selected By ICON To Evolve Image Management And Accelerate Research Goals For Sponsors And Sites During Clinical Trials

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, and ICON (NASDAQ: ICLR), a global provider of drug development solutions and services to the...

ICON Contributes To Major European Research Study That Aims To Improve Treatment For Traumatic Brain Injury

ICON Contributes To Major European Research Study That Aims To Improve Treatment For Traumatic Brain Injury

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has contributed to a complex pan-European...

ICON Reveals Voice-Assistant Applications For Clinical Trials At ISPOR Annual European Congress

ICON Reveals Voice-Assistant Applications For Clinical Trials At ISPOR Annual European Congress

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today revealed proof-of-concept developments leveraging Voice...

ICON And The International Consortium For Health Outcomes Measurement Unveil The World's First Global Patient Outcomes Benchmarking Platform

ICON And The International Consortium For Health Outcomes Measurement Unveil The World's First Global Patient Outcomes Benchmarking Platform

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and the International Consortium for Health Outcomes Measurement...

ICON Reports Third Quarter 2017 Results

ICON Reports Third Quarter 2017 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter...

ICON Announces Appointment Of Mr. Eugene McCague To Board Of Directors

ICON Announces Appointment Of Mr. Eugene McCague To Board Of Directors

ICON plc , (NASDAQ: ICLR) global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Mr.

ICON Acquires Mapi Group

ICON Acquires Mapi Group

ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired the Mapi Group, a leading...

ICON Reports Second Quarter 2017 Results

ICON Reports Second Quarter 2017 Results

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter...

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions at the Annual General...

ICON Wins ELearning And Animation Awards For Its FIRECREST Digital Solutions

ICON Wins ELearning And Animation Awards For Its FIRECREST Digital Solutions

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that its FIRECREST solutions have won gold and...

ICON And DIA Amplify Thought Leadership And Debate With DIA Live 2017

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that for the second consecutive year it will present...

ICON Named By Forbes As One Of The Best Employers In America

ICON plc , (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been included in Forbes...

ICON Reports First Quarter 2017 Results

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter...

Parexel Is Discovering the Drugs of the Future

Parexel Is Discovering the Drugs of the Future

The midcap drug maker is finding growth as an outsourcing destination.

ICON Selected By The FDA To Validate Patient-Reported Outcome Endpoints For Antibacterial Drug Trials

ICON plc , (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a project by the US...

TheStreet Quant Rating: A (Buy)